Navaneeth Narayanan

983 total citations
47 papers, 659 citations indexed

About

Navaneeth Narayanan is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, Navaneeth Narayanan has authored 47 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 19 papers in Epidemiology and 13 papers in Clinical Biochemistry. Recurrent topics in Navaneeth Narayanan's work include Bacterial Identification and Susceptibility Testing (13 papers), Antibiotic Use and Resistance (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Navaneeth Narayanan is often cited by papers focused on Bacterial Identification and Susceptibility Testing (13 papers), Antibiotic Use and Resistance (10 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Navaneeth Narayanan collaborates with scholars based in United States, Netherlands and United Kingdom. Navaneeth Narayanan's co-authors include Jared Radbel, Conan MacDougall, Tanaya Bhowmick, Kendall Gross, Christopher Fee, Luigi Brunetti, Melvin P. Weinstein, Stephanie Shiau, Ronald Nahass and Christopher H Pham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Navaneeth Narayanan

41 papers receiving 647 citations

Peers

Navaneeth Narayanan
Whitney R. Buckel United States
Nicholas J. Mercuro United States
Noah Wald‐Dickler United States
Mervyn Mer South Africa
Sarah Warner United States
Navaneeth Narayanan
Citations per year, relative to Navaneeth Narayanan Navaneeth Narayanan (= 1×) peers Nobuaki Matsunaga

Countries citing papers authored by Navaneeth Narayanan

Since Specialization
Citations

This map shows the geographic impact of Navaneeth Narayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Navaneeth Narayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Navaneeth Narayanan more than expected).

Fields of papers citing papers by Navaneeth Narayanan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Navaneeth Narayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Navaneeth Narayanan. The network helps show where Navaneeth Narayanan may publish in the future.

Co-authorship network of co-authors of Navaneeth Narayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Navaneeth Narayanan. A scholar is included among the top collaborators of Navaneeth Narayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Navaneeth Narayanan. Navaneeth Narayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narayanan, Navaneeth, et al.. (2025). (Val)ganciclovir dosing for cytomegalovirus: revisiting the 2005 Wiltshire et al. pharmacokinetic/pharmacodynamic target. SHILAP Revista de lepidopterología. 3(1). 105171–105171.
2.
Narayanan, Navaneeth, et al.. (2025). P-132. Retrospective Comparison of Short and Prolonged Treatment Strategies for Patients with Neutropenic Enterocolitis. Open Forum Infectious Diseases. 12(Supplement_1).
3.
McLeod, Sarah M., John P. O’Donnell, Navaneeth Narayanan, John Mills, & Keith S. Kaye. (2024). Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii. Future Microbiology. 19(7). 563–576. 15 indexed citations
5.
Jimenez, Humberto R., et al.. (2024). Association between Socioeconomic Status and Vaccination Hesitancy, Reluctancy and Confidence among Asian-Americans Living in the State of New Jersey. Journal of Community Health. 49(5). 829–834. 1 indexed citations
6.
Azim, Ahmed Abdul, et al.. (2023). Rapid Diagnostics to Enhance Therapy Selection for the Treatment of Bacterial Infections. Current Pharmacology Reports. 9(4). 198–216. 7 indexed citations
7.
Nelson, George E., Navaneeth Narayanan, Sharon Onguti, et al.. (2023). Principles and Practice of Antimicrobial Stewardship Program Resource Allocation. Infectious Disease Clinics of North America. 37(4). 683–714. 5 indexed citations
8.
Narayanan, Navaneeth, et al.. (2023). Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia. SHILAP Revista de lepidopterología. 3(1). e22–e22. 7 indexed citations
9.
Bridgeman, Mary Barna, Michael Toscani, Racquel E. Kohler, et al.. (2021). Pharmacists’ Perceptions and Drivers of Immunization Practices for COVID-19 Vaccines: Results of a Nationwide Survey Prior to COVID-19 Vaccine Emergency Use Authorization. SHILAP Revista de lepidopterología. 9(3). 131–131. 9 indexed citations
10.
Khan, Anzalee, Nikhil Yegya‐Raman, Sinae Kim, et al.. (2021). Montelukast in hospitalized patients diagnosed with COVID-19. Journal of Asthma. 59(4). 780–786. 52 indexed citations
11.
Narayanan, Navaneeth, et al.. (2021). Characterization of predictors of ESBL‐producing enterobacteriaceae in urine cultures of emergency department patients. SHILAP Revista de lepidopterología. 2(1). e12345–e12345. 2 indexed citations
12.
Narayanan, Navaneeth, et al.. (2021). Relationship Between Multidrug-Resistant Enterobacterales and Obesity in Older Adults. Infection and Drug Resistance. Volume 14. 2527–2532. 4 indexed citations
13.
Narayanan, Navaneeth, et al.. (2019). <p>Evaluation of treatment options for methicillin-resistant <em>Staphylococcus aureus</em> infections in the obese patient</p>. Infection and Drug Resistance. Volume 12. 877–891. 7 indexed citations
15.
Narayanan, Navaneeth, et al.. (2019). Selective antibiotic susceptibility reporting and broad-spectrum intravenous antibiotic use: A multicentre ecological study. International Journal of Antimicrobial Agents. 54(3). 367–370. 5 indexed citations
16.
Hogan, Michael, et al.. (2018). Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of <em>Pseudomonas aeruginosa</em> infections. Infection and Drug Resistance. Volume 11. 1975–1981. 6 indexed citations
17.
19.
Narayanan, Navaneeth, et al.. (2015). Effect of an electronic medical record alert for severe sepsis among ED patients. The American Journal of Emergency Medicine. 34(2). 185–188. 55 indexed citations
20.
Narayanan, Navaneeth, et al.. (2006). Arabinose-Induction of lac-Derived Promoter Systems for Penicillin Acylase Production in Escherichia coli. Biotechnology Progress. 22(3). 617–625. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026